News

Documenting his experiences has proven to be the outlet Darin Nakakihara needs in the wake of his ALS diagnosis.
The U.S. FDA has granted orphan drug designation to Klotho Neurosciences Inc.’s secreted-Klotho (s-KL) promoter, gene and ...
Columnist Dagmar Munn shares how she finds ways to keep her anxiety and ALS fears in check with a few simple responses.
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...
There were support groups and he would eventually join an ALS clinic, but no one was documenting the day-to-day of the ...